Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 110

1.

Neurosarcoidosis Occurring 6 Years after Onset of Vogt-Koyanagi-Harada Disease.

Sehara Y, Otsuka H, Sakamoto S, Ando Y, Sawada M, Sehara Y.

Case Rep Ophthalmol. 2019 Jan 24;10(1):32-40. doi: 10.1159/000496384. eCollection 2019 Jan-Apr.

2.

Intravesical irrigation might prevent bladder recurrence in patients undergoing radical nephroureterectomy for upper urinary tract urothelial carcinoma.

Yamamoto S, Sakamoto S, Imamura Y, Sazuka T, Nakamura K, Inoue T, Chiba K, Miyazaki K, Inoue A, Nagata M, Ichikawa T.

Int J Urol. 2019 May 12. doi: 10.1111/iju.14014. [Epub ahead of print]

PMID:
31081198
3.

Editorial Comment to The Urological Association of Asia clinical guideline for urinary stone disease.

Sakamoto S.

Int J Urol. 2019 Apr 24. doi: 10.1111/iju.13958. [Epub ahead of print] No abstract available.

PMID:
31016809
4.

Higher Serum Testosterone Levels Associated with Favorable Prognosis in Enzalutamide- and Abiraterone-Treated Castration-Resistant Prostate Cancer.

Sakamoto S, Maimaiti M, Xu M, Kamada S, Yamada Y, Kitoh H, Matsumoto H, Takeuchi N, Higuchi K, Uchida HA, Komiya A, Nagata M, Nakatsu H, Matsuyama H, Akakura K, Ichikawa T.

J Clin Med. 2019 Apr 11;8(4). pii: E489. doi: 10.3390/jcm8040489.

5.

Role of pre-miR-532 (miR-532-5p and miR-532-3p) in regulation of gene expression and molecular pathogenesis in renal cell carcinoma.

Yamada Y, Arai T, Kato M, Kojima S, Sakamoto S, Komiya A, Naya Y, Ichikawa T, Seki N.

Am J Clin Exp Urol. 2019 Feb 18;7(1):11-30. eCollection 2019.

6.

Shortening of Interpupillary Distance after Instillation of Topical Prostaglandin Analogue Eye Drops.

Sano I, Takahashi H, Inoda S, Sakamoto S, Arai Y, Takahashi Y, Ohkubo A, Kawashima H, Mayama C.

Am J Ophthalmol. 2019 Mar 19. pii: S0002-9394(19)30119-9. doi: 10.1016/j.ajo.2019.03.013. [Epub ahead of print]

PMID:
30902695
7.

Chronological changes in epidemiological characteristics of lower urinary tract urolithiasis in Japan.

Sakamoto S, Miyazawa K, Yasui T, Iguchi T, Fujita M, Nishimatsu H, Masaki T, Hasegawa T, Hibi H, Arakawa T, Ando R, Kato Y, Ishito N, Yamaguchi S, Takazawa R, Tsujihata M, Taguchi M, Akakura K, Hata A, Ichikawa T.

Int J Urol. 2019 Jan;26(1):96-101. doi: 10.1111/iju.13817. Epub 2018 Oct 11.

PMID:
30308705
8.

Differentiation of Brain Metastases and Gliomas Based on Color Map of Phase Difference Enhanced Imaging.

Doishita S, Sakamoto S, Yoneda T, Uda T, Tsukamoto T, Yamada E, Yoneyama M, Kimura D, Katayama Y, Tatekawa H, Shimono T, Ohata K, Miki Y.

Front Neurol. 2018 Sep 21;9:788. doi: 10.3389/fneur.2018.00788. eCollection 2018.

9.

Intravitreal aflibercept for exudative age-related macular degeneration with good visual acuity: 2-year results of a prospective study.

Sakamoto S, Takahashi H, Inoue Y, Arai Y, Inoda S, Kakinuma N, Fujino Y, Tanabe T, Kawashima H, Yanagi Y.

Clin Ophthalmol. 2018 Jun 25;12:1137-1147. doi: 10.2147/OPTH.S160961. eCollection 2018.

10.

Editorial Comment to Epidemiology of prostate cancer in Asian countries.

Sakamoto S.

Int J Urol. 2018 Jun;25(6):531-532. doi: 10.1111/iju.13707. No abstract available.

PMID:
29883043
11.

Editorial Comment from Dr Sakamoto to Risk of urinary stones among women with pelvic organ prolapse: A national population-based cohort study.

Sakamoto S.

Int J Urol. 2018 Sep;25(9):837-838. doi: 10.1111/iju.13701. Epub 2018 May 31. No abstract available.

PMID:
29855087
12.

Treatment strategy for metastatic prostate cancer with extremely high PSA level: reconsidering the value of vintage therapy.

Yamada Y, Sakamoto S, Amiya Y, Sasaki M, Shima T, Komiya A, Suzuki N, Akakura K, Ichikawa T, Nakatsu H.

Asian J Androl. 2018 Sep-Oct;20(5):432-437. doi: 10.4103/aja.aja_24_18.

13.

Editorial Comment to Local treatment for metastatic prostate cancer: A systematic review.

Sakamoto S.

Int J Urol. 2018 May;25(5):403-404. doi: 10.1111/iju.13588. No abstract available.

14.

Imaging features of benign mass lesions in the nasal cavity and paranasal sinuses according to the 2017 WHO classification.

Tatekawa H, Shimono T, Ohsawa M, Doishita S, Sakamoto S, Miki Y.

Jpn J Radiol. 2018 Jun;36(6):361-381. doi: 10.1007/s11604-018-0739-y. Epub 2018 Apr 25. Review.

PMID:
29696477
15.

Contralateral adrenal width predicts the duration of prolonged post-surgical steroid replacement for subclinical Cushing syndrome.

Sugiura M, Imamura Y, Kawamura K, Yamamoto S, Sazuka T, Nakamura K, Sakamoto S, Nagano H, Koide H, Tanaka T, Imamoto T, Komiya A, Ichikawa T.

Int J Urol. 2018 Jun;25(6):583-588. doi: 10.1111/iju.13566. Epub 2018 Apr 12.

PMID:
29651813
16.

Chronological changes in the epidemiological characteristics of upper urinary tract urolithiasis in Japan.

Sakamoto S, Miyazawa K, Yasui T, Iguchi T, Fujita M, Nishimatsu H, Masaki T, Hasegawa T, Hibi H, Arakawa T, Ando R, Kato Y, Ishito N, Yamaguchi S, Takazawa R, Tsujihata M, Matsuda T, Akakura K, Hata A, Ichikawa T.

Int J Urol. 2018 Apr;25(4):373-378. doi: 10.1111/iju.13552.

17.

Biparametric Prostate Imaging Reporting and Data System version2 and International Society of Urological Pathology Grade Predict Biochemical Recurrence after Radical Prostatectomy.

Takeuchi N, Sakamoto S, Nishiyama A, Horikoshi T, Yamada Y, Iizuka J, Maimaiti M, Imamura Y, Kawamura K, Imamoto T, Komiya A, Ikehara Y, Akakura K, Ichikawa T.

Clin Genitourin Cancer. 2018 Aug;16(4):e817-e829. doi: 10.1016/j.clgc.2018.02.011. Epub 2018 Feb 24.

PMID:
29576444
18.

Visual acuity loss associated with excessive "dry macula" in exudative age-related macular degeneration.

Takahashi H, Inoue Y, Tan X, Inoda S, Sakamoto S, Arai Y, Yanagi Y, Fujino Y, Kawashima H.

Clin Ophthalmol. 2018 Feb 20;12:369-375. doi: 10.2147/OPTH.S151999. eCollection 2018.

19.

An equivalent fluid model based finite-difference time-domain algorithm for sound propagation in porous material with rigid frame.

Zhao J, Bao M, Wang X, Lee H, Sakamoto S.

J Acoust Soc Am. 2018 Jan;143(1):130. doi: 10.1121/1.5020268.

PMID:
29390758
20.

Editorial Comment to Cell death under epithelial-mesenchymal transition control in prostate cancer therapeutic response.

Sakamoto S.

Int J Urol. 2018 Apr;25(4):326. doi: 10.1111/iju.13510. Epub 2018 Jan 17. No abstract available.

Supplemental Content

Loading ...
Support Center